Comparison of the effect of two methods of cabergoline administration to prevent ovarian hyperstimulation syndrome in women with polycystic ovary syndrome
Phase 3
Recruiting
- Conditions
- Polycystic ovarian syndrome.Polycystic ovarian syndromeE28.2
- Registration Number
- IRCT20090526001952N16
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 200
Inclusion Criteria
Age range of 18 to 45 years old
Patients with polycystic ovary syndrome
high level of anti-müllerian hormone (AMH) level (> 3 ng/ml) and/or high antral follicle count (AFC)>20
Exclusion Criteria
Allergy to cabergoline
Not taking the drug completely
Stopping the drug due to side effects or drug sensitivity
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Ovarian hyperstimulation syndrome. Timepoint: Three days after pancture. Method of measurement: Ultrasound and clinical findings.
- Secondary Outcome Measures
Name Time Method